Developer docs
API playgroundTry for free, no card

Search company profiles

NanoFCM

Full company profile

uuid000hvii

Namestring
NanoFCM
Legal namestring
NanoFCM Co., Ltd.
Websiteurl
nanofcm.com
Company typeenum
Private
Founded yearint
2018
Descriptiontext

NanoFCM is a privately held scientific-instrument company that designs and manufactures nano-flow cytometry platforms for single-particle analysis of biological nanoparticles in the 7–1000 nm range. The company's product stack centers on two instruments—the Flow NanoAnalyzer, which combines light-scattering sizing/concentration measurement with multi-channel fluorescence detection, and the Single-Molecule NanoAnalyzer, which extends detection to individual fluorophores, proteins, and mRNAs for cargo-loading quantification on LNPs and extracellular vesicles. A supporting reagents and consumables line (calibration standards, fluorescent quantification reagents, fluorescent antibodies) generates recurring revenue, while a sample-analysis services offering provides contract characterization for customers who prefer outsourced workups. The firm is incorporated as NanoFCM Co., Ltd. in Xiamen, China, and operates an EMEA Operations Center in Stevenage, UK, a Singapore APAC office, plus a North America sales and applications function, reaching customers in at least 30 countries through both direct sales and a network of regional distributors.

The company sells primarily to biopharmaceutical and vaccine/gene therapy developers—including 80% of the Top 20 biopharma, per company-cited scale metrics—who require single-particle characterization of LNPs, extracellular vesicles, viral vectors, and other nanomedicines for drug development and quality control. Secondary segments include academic and clinical research laboratories and clinical/food-safety applications. Pricing is not publicly disclosed and follows a quote-based, demo-led enterprise sales motion supplemented by technical webinars, peer-reviewed publication references (1,000+ cumulative citations), and platinum-level sponsorship of the ISEV annual meeting for seven consecutive years (2018–2026). Distribution is structured around direct enterprise sales plus exclusive arrangements such as DKSH for selected Asian markets and a growing approved service-provider network (RoosterBio in the US).

Operationally, NanoFCM reported 11–50 employees, no disclosed funding rounds or parent entity, and no published revenue. The 2024 launch of an industrial flagship (Flow NanoAnalyzer Flare) and a high-throughput nano-flow system (Auto20) marks the firm's most material product move and indicates a strategic shift from research-grade sale toward regulated bioprocess QC use cases.

Short descriptiontext

NanoFCM is a privately held instrumentation company that builds nano-flow cytometry platforms (Flow NanoAnalyzer, Single-Molecule NanoAnalyzer) plus reagents and sample-analysis services for single-particle characterization of biological nanoparticles (7–1000 nm), serving biopharmaceutical developers, vaccine/gene therapy researchers, and academic labs across 30+ countries.

Operating statusenum
Operating
Ownership categoryenum
Headcount rangeband
11–50
akta.pro rankint
HeadquartersXiamen, China
HQ citystring
Xiamen
HQ countrystring
China
HQ regionstring
Asia
Markets served

Serves global market

Offices4 records

Each record includes

City, Country, Type, Description, Source

Keyword5 values
nano-flow cytometry, nanoparticle characterization, extracellular vesicle analysis, single-molecule detection, analytical instrumentation
Industry3 codes
PRIMARYHLAGAIAE
Microscopy, Imaging & Flow Cytometry Instruments
SECONDARYHLAHAAAF
Flow Cytometry & Cellular Analysis Diagnostics
Healthcare & Life Sciences/Medical Devices & Diagnostics/In Vitro Diagnostics (IVD) & Laboratory Diagnostics
SECONDARYHLAGADAK
Material Characterization & Spectroscopy (NMR/FTIR/MS)
NAICS code2 codes
  • Analytical Laboratory Instrument Manufacturing334516
  • Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology)541715
SIC code2 codes
  • Laboratory Analytical Instruments3826
  • Services-Commercial Physical & Biological Research8731
Product category
Analytical Instrumentation
GTM motion1 record

Each record includes

Type, Description, Source

Revenue model3 records
1Flow NanoAnalyzer Instruments
TypeHardware Sales
Description

Sale of analytical instruments (Flow NanoAnalyzer, Single-Molecule NanoAnalyzer) for nanoparticle characterization. Instruments enable multiparameter analysis of biological nanoparticles at single-particle level for research and quality control applications.

nanofcm.com
2Reagents and Consumables
TypeHardware Sales
Description

Sale of supporting reagents including quality control materials, size standards, fluorescent quantification reagents, and fluorescent antibodies for use with NanoAnalyzer platforms.

nanofcm.com
3Sample Analysis Services
TypeProfessional Services
Description

Contract analytical services using NanoAnalyzer platform, offered through service provider partnerships like RoosterBio. Sample analysis services for extracellular vesicle characterization.

nanofcm.com
Marketing channels5 records

Each record includes

Title, Type, Stage, Description, Source

Distribution channels4 records

Each record includes

Title, Type, Scope, Target buyer, Description, Source

Cost components6 values
Technology or R&D, Personnel, Supply Chain, Marketing or Sales, Operations, Infrastructure
GTM typeB2B
B2B
Offering typeHardware or Manufacturing
Hardware or Manufacturing
Brand1 of 2 records shown
1Flow NanoAnalyzer
Description

Main product platform for multiparameter analysis of functional nanoparticles (7-1000 nm) at single-particle level, combining light scattering for size measurement and fluorescence detection for biochemical characterization

nanofcm.com
+1 more record
Core offering1 text field

NanoFCM designs, manufactures, and sells nano-flow cytometry instruments (Flow NanoAnalyzer and Single-Molecule NanoAnalyzer) for multiparameter analysis of individual biological nanoparticles in the 7-1000 nm range. The company combines light scattering for size/concentration measurement with fluorescence detection for biochemical characterization, and also supplies supporting reagents, consumables, and contract sample analysis services for biopharma and academic customers.

Differentiator
Functional benefit
Problem solved
Quantifiable outcome1 of 4 values shown
  • Size resolution comparable to TEM with fast acquisition times of 1-2 minutes
+3 more records
Product overview1 text field

NanoFCM provides a unified platform of nanoparticle characterization instruments centered on the Flow NanoAnalyzer and Single-Molecule NanoAnalyzer, both designed for multiparameter analysis of biological nanoparticles (7-1000 nm) at the single-particle level. The Flow NanoAnalyzer combines light scattering and fluorescence detection for simultaneous size, concentration, and biochemical property measurement, while the Single-Molecule NanoAnalyzer extends this capability to detect individual fluorophores, proteins, and mRNAs for detailed molecular characterization. Supporting these instruments are reagent and consumable products plus sample analysis services, enabling comprehensive nanoparticle characterization across applications including extracellular vesicles, nanomedicines, vaccines, viruses, and bacteria.

Product and service4 records
1Flow NanoAnalyzer
CategoryAnalytical Instrument
Description

High-sensitivity flow cytometry system for multiparameter characterization of nanoparticles (7-1000 nm) at the single-particle level, combining light scattering for size/concentration measurement with fluorescence detection for biochemical property analysis; sold to biopharma and research institutions.

2Single-Molecule NanoAnalyzer
CategoryAnalytical Instrument
Description

Advanced single-molecule detection platform for analyzing individual fluorophores, proteins, and mRNAs, enabling characterization of extracellular vesicles, mRNA LNPs, and viral vectors at the single-molecule level for nanobiological drug loading applications.

3Reagents and Consumables
CategoryReagents and Consumables
Description

Quality control reagents, size standards, fluorescent quantification reagents, and fluorescent antibodies designed for use with Flow NanoAnalyzer systems.

4Sample Analysis Services
CategoryAnalytical Service
Description

Contract analytical services for nanoparticle characterization using the NanoAnalyzer platform, including exosome/EV analysis, LNP characterization, and custom nanoparticle analysis, offered directly and through approved service providers such as RoosterBio.

Scale indicator4 records

Each record includes

Type, Value, Description, Source

Partnership7 partners
Strategic tierMajorTypeChannel Partner/ Reseller/ DistributorAnnounced on2023-04-26
Description

Strategic partnership making RoosterBio the first US-based approved service provider for exosome/EV analytical services using NanoFCM's NanoAnalyzer. RoosterBio offers contract analytical services integrating NanoAnalyzer technology within exosome process development programs and provides expert knowledge for protocol development.

Strategic tierMajorTypeChannel Partner/ Reseller/ DistributorAnnounced on2021-02-01
Description

Exclusive partnership for marketing, sales, distribution and after-sales service support in selected Asian markets including Singapore, Taiwan, and Thailand. DKSH provides local market access and distribution infrastructure for NanoFCM's analytical instruments.

3Cyto-Logic
Strategic tierMinorTypeChannel Partner/ Reseller/ Distributor
Description

Regional distribution partner for Poland. Contact: mkonieczny@cyto-logic.pl

nanofcm.com
Strategic tierMinorTypeChannel Partner/ Reseller/ Distributor
Description

Regional distribution partner for Czech Republic. Contact: sales@anamet.cz

Strategic tierMinorTypeChannel Partner/ Reseller/ Distributor
Description

Regional distribution partner for Taiwan, China. Contact: +886 2 2695 9990

6Meiwafosis Co., Ltd.
Strategic tierMinorTypeChannel Partner/ Reseller/ Distributor
Description

Regional distribution partner for Japan. Contact: international@meiwanet.co.jp

nanofcm.com
Strategic tierMinorTypeChannel Partner/ Reseller/ Distributor
Description

Regional distribution partner for Australia. Contact: sales@newspec.com.au

Recent move5 records

Each record includes

Date, Type, Title, Description, Source

Expansion highlight6 records

Each record includes

Type, Description

Peers10 records
TypeEmerging player
Description

Supplies exosome/EV reagents, antibodies, and isolation kits (ExoDx, ExoQuick). Overlaps with NanoFCM's reagent/consumables business and shares the same EV-research customer base, creating both partnership and competitive dynamics.

TypeDirect peer
Description

Maker of ZetaView NTA systems that compete head-to-head with NanoFCM in EV/exosome quantification and characterization. Both target academic core facilities and biopharma process development with comparable single-particle workflows.

TypeDirect peer
Description

Maker of NanoSight Nanoparticle Tracking Analysis instruments, which is the most widely used competing technique for sub-micron particle sizing. Both NanoFCM and NanoSight target EV, LNP, and exosome characterization workflows in biopharma and academia.

TypeBroad incumbent
Description

Dominant flow cytometry incumbent (CytoFLEX, Navios, DxFLEX) with broad biopharma and clinical diagnostics reach. NanoFCM directly extends flow cytometry into the sub-500 nm range Beckman does not cover, making Beckman the most strategically relevant incumbent — and the most likely large competitor.

TypeEmerging player
Description

Single-EV analysis platform (ExoView) using microarray-based immunocapture plus interferometric imaging. Direct competitor in the EV characterization market, frequently co-cited with NanoFCM in EV research publications.

TypeEmerging player
Description

MSC and EV bioprocess supplier and NanoFCM's first US approved service provider for exosome/EV analytical services. Although a partner, RoosterBio also develops its own EV analytics offerings and competes for the same biopharma EV development budget.

TypeBroad incumbent
Description

Global flow cytometry leader (BD FACSDiscover, BD Symphony) with the largest installed base in pharma and academia. BD has the resources to enter the nano-flow space and already supplies the broader cell-analysis workflow in which NanoFCM's EV/virus customers operate.

TypeDirect peer
Description

Developer of qNano / TRPS tunable resistive pulse sensing instruments for single-particle nanoparticle sizing and concentration. Izon is the closest alternative technique to NanoFCM's single-particle analysis, serving overlapping EV, virus, and LNP characterization markets.

TypeEmerging player
Description

Spectral flow cytometry innovator (Aurora, Northern Lights) bringing advanced flow-based cell analysis to immunology, cell therapy, and oncology. Overlaps with NanoFCM in serving cell-therapy and EV analytical workflows using flow-based single-particle measurement.

TypeEmerging player
Description

Maker of nCS1 Microfluidic Resistive Pulse Sensing instruments for nanoparticle sizing and concentration. Competes with NanoFCM directly in LNP, EV, and viral vector characterization, particularly in biopharma QC.

Market position
Strengths5 records

Each record includes

Headline, Details, Source

Weaknesses5 records

Each record includes

Headline, Details, Source

Competitive moat5 records

Each record includes

Type, Details

Key risks6 records

Each record includes

Headline, Details, Source

Key highlights7 records

Each record includes

Headline, Details, Source

Customer concentration

Classification, Details

Named customers3 records

Each record includes

Name, Industry, Type, Use case, Source, UUID

Segment3 records

Each record includes

Title, Type, Primary, Description, Pain point addressed, Use case, Source

Ideal customer profile3 records

Each record includes

Profile, Firmographic size, Sales motion, Sales cycle length, Buying structure, Purchase trigger, Buyer persona, Geography, Industry vertical, Primary use case, Description, Pain points, Evidence proof points, Target buyer

Technology focused
Yes
API detail
Has APIbool
No

Docs URL, Description

AI maturity
App detail

Has app

Feature6 records

Each record includes

Title, Differentiator, Description, Source

Core technology
Revenue estimate
Valuation estimate
Number of profiles
Profiles2 records

Each record includes

Name, Designation, Designation category, Overview, Profile commentary, Source

No data
No data
Funding overview

Funding stage, Last funding date, Total funding USD

Funding rounds

Each record includes

Round, Amount USD, Date, Pre money valuation, Total investors, Investors, News

Investors

Each record includes

Name, Type, Date of entry, Rounds participated, Website

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Each record includes

Name, Acquisition type, Announced date, Completed date, Status, Website, News

Investment

Each record includes

Name, Round, Announced date, Lead investor, Website, News

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

NanoFCM

Analytical Instrumentationnanofcm.com

NanoFCM is a privately held instrumentation company that builds nano-flow cytometry platforms (Flow NanoAnalyzer, Single-Molecule NanoAnalyzer) plus reagents and sample-analysis services for single-particle characterization of biological nanoparticles (7–1000 nm), serving biopharmaceutical developers, vaccine/gene therapy researchers, and academic labs across 30+ countries.

What NanoFCM does

NanoFCM is a privately held scientific-instrument company that designs and manufactures nano-flow cytometry platforms for single-particle analysis of biological nanoparticles in the 7–1000 nm range. The company's product stack centers on two instruments—the Flow NanoAnalyzer, which combines light-scattering sizing/concentration measurement with multi-channel fluorescence detection, and the Single-Molecule NanoAnalyzer, which extends detection to individual fluorophores, proteins, and mRNAs for cargo-loading quantification on LNPs and extracellular vesicles. A supporting reagents and consumables line (calibration standards, fluorescent quantification reagents, fluorescent antibodies) generates recurring revenue, while a sample-analysis services offering provides contract characterization for customers who prefer outsourced workups. The firm is incorporated as NanoFCM Co., Ltd. in Xiamen, China, and operates an EMEA Operations Center in Stevenage, UK, a Singapore APAC office, plus a North America sales and applications function, reaching customers in at least 30 countries through both direct sales and a network of regional distributors.

The company sells primarily to biopharmaceutical and vaccine/gene therapy developers—including 80% of the Top 20 biopharma, per company-cited scale metrics—who require single-particle characterization of LNPs, extracellular vesicles, viral vectors, and other nanomedicines for drug development and quality control. Secondary segments include academic and clinical research laboratories and clinical/food-safety applications. Pricing is not publicly disclosed and follows a quote-based, demo-led enterprise sales motion supplemented by technical webinars, peer-reviewed publication references (1,000+ cumulative citations), and platinum-level sponsorship of the ISEV annual meeting for seven consecutive years (2018–2026). Distribution is structured around direct enterprise sales plus exclusive arrangements such as DKSH for selected Asian markets and a growing approved service-provider network (RoosterBio in the US).

Operationally, NanoFCM reported 11–50 employees, no disclosed funding rounds or parent entity, and no published revenue. The 2024 launch of an industrial flagship (Flow NanoAnalyzer Flare) and a high-throughput nano-flow system (Auto20) marks the firm's most material product move and indicates a strategic shift from research-grade sale toward regulated bioprocess QC use cases.

NanoFCM firmographics

Firmographics
Name
NanoFCM
Legal name
NanoFCM Co., Ltd.
Website
https://nanofcm.com
Company type
Private
Founded year
2018
Operating status
Operating
Headcount range
11–50 employees
Short description
NanoFCM is a privately held instrumentation company that builds nano-flow cytometry platforms (Flow NanoAnalyzer, Single-Molecule NanoAnalyzer) plus reagents and sample-analysis services for single-particle characterization of biological nanoparticles (7–1000 nm), serving biopharmaceutical developers, vaccine/gene therapy researchers, and academic labs across 30+ countries.
Ownership category
akta.pro rank

NanoFCM industry classification

Industry
Product category
Analytical Instrumentation
NAICS
Analytical Laboratory Instrument Manufacturing (334516), Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology) (541715)
SIC
Laboratory Analytical Instruments (3826), Services-Commercial Physical & Biological Research (8731)
akta.pro industry
PRIMARYHLAGAIAE
Microscopy, Imaging & Flow Cytometry Instruments
SECONDARYHLAHAAAF
Flow Cytometry & Cellular Analysis Diagnostics
Healthcare & Life Sciences/Medical Devices & Diagnostics/In Vitro Diagnostics (IVD) & Laboratory Diagnostics
SECONDARYHLAGADAK
Material Characterization & Spectroscopy (NMR/FTIR/MS)

Keywords

  • Nano-flow cytometry
  • Nanoparticle characterization
  • Extracellular vesicle analysis
  • Single-molecule detection
  • Analytical instrumentation

Where NanoFCM is headquartered

Location

Headquarters

HQ city
Xiamen
HQ country
China
HQ region
Asia

Offices4 records

Markets served

NanoFCM business model

Business model
GTM type
B2B
Offering type
Hardware or Manufacturing
Cost components
Technology or R&D, Personnel, Supply Chain, Marketing or Sales, Operations, Infrastructure

Revenue model

  1. Flow NanoAnalyzer Instruments: Sale of analytical instruments (Flow NanoAnalyzer, Single-Molecule NanoAnalyzer) for nanoparticle characterization. Instruments enable multiparameter analysis of biological nanoparticles at single-particle level for research and quality control applications.
  2. Reagents and Consumables: Sale of supporting reagents including quality control materials, size standards, fluorescent quantification reagents, and fluorescent antibodies for use with NanoAnalyzer platforms.
  3. Sample Analysis Services: Contract analytical services using NanoAnalyzer platform, offered through service provider partnerships like RoosterBio. Sample analysis services for extracellular vesicle characterization.

Go-to-market motion1 record

Distribution channels4 records

Marketing channels5 records

NanoFCM product offering

Product offering

Core offering

NanoFCM designs, manufactures, and sells nano-flow cytometry instruments (Flow NanoAnalyzer and Single-Molecule NanoAnalyzer) for multiparameter analysis of individual biological nanoparticles in the 7-1000 nm range. The company combines light scattering for size/concentration measurement with fluorescence detection for biochemical characterization, and also supplies supporting reagents, consumables, and contract sample analysis services for biopharma and academic customers.

Product overview

NanoFCM provides a unified platform of nanoparticle characterization instruments centered on the Flow NanoAnalyzer and Single-Molecule NanoAnalyzer, both designed for multiparameter analysis of biological nanoparticles (7-1000 nm) at the single-particle level. The Flow NanoAnalyzer combines light scattering and fluorescence detection for simultaneous size, concentration, and biochemical property measurement, while the Single-Molecule NanoAnalyzer extends this capability to detect individual fluorophores, proteins, and mRNAs for detailed molecular characterization. Supporting these instruments are reagent and consumable products plus sample analysis services, enabling comprehensive nanoparticle characterization across applications including extracellular vesicles, nanomedicines, vaccines, viruses, and bacteria.

Differentiator

Problem solved

Functional benefit

Brands

  • Flow NanoAnalyzer: Main product platform for multiparameter analysis of functional nanoparticles (7-1000 nm) at single-particle level, combining light scattering for size measurement and fluorescence detection for biochemical characterization
  • Single-Molecule NanoAnalyzer

Products and services

  • Flow NanoAnalyzer High-sensitivity flow cytometry system for multiparameter characterization of nanoparticles (7-1000 nm) at the single-particle level, combining light scattering for size/concentration measurement with fluorescence detection for biochemical property analysis; sold to biopharma and research institutions.
  • Single-Molecule NanoAnalyzer Advanced single-molecule detection platform for analyzing individual fluorophores, proteins, and mRNAs, enabling characterization of extracellular vesicles, mRNA LNPs, and viral vectors at the single-molecule level for nanobiological drug loading applications.
  • Reagents and Consumables Quality control reagents, size standards, fluorescent quantification reagents, and fluorescent antibodies designed for use with Flow NanoAnalyzer systems.
  • Sample Analysis Services Contract analytical services for nanoparticle characterization using the NanoAnalyzer platform, including exosome/EV analysis, LNP characterization, and custom nanoparticle analysis, offered directly and through approved service providers such as RoosterBio.

Quantifiable outcome

  • Size resolution comparable to TEM with fast acquisition times of 1-2 minutes
  • +3 more outcomes

Companies that use NanoFCM

Customer profile

Named customers3 records

Segments3 records

Ideal customer profiles3 records

NanoFCM technology and API

Technology

Technology focussed Yes

API detail

Has API
No
API docs
API detail

Core technology

AI maturity

App detail

Feature6 records

NanoFCM partnerships and signals

Strategic signal

Partnerships

Seven partnerships are on record, tiered major and minor.

  • RoosterBiomajorChannel Partner/ Reseller/ Distributor · 26 April 2023Strategic partnership making RoosterBio the first US-based approved service provider for exosome/EV analytical services using NanoFCM's NanoAnalyzer. RoosterBio offers contract analytical services integrating NanoAnalyzer technology within exosome process development programs and provides expert knowledge for protocol development.
  • DKSH TechnologymajorChannel Partner/ Reseller/ Distributor · 1 February 2021Exclusive partnership for marketing, sales, distribution and after-sales service support in selected Asian markets including Singapore, Taiwan, and Thailand. DKSH provides local market access and distribution infrastructure for NanoFCM's analytical instruments.
  • Cyto-LogicminorChannel Partner/ Reseller/ DistributorRegional distribution partner for Poland. Contact: mkonieczny@cyto-logic.pl
  • ANAMET s.r.o.minorChannel Partner/ Reseller/ DistributorRegional distribution partner for Czech Republic. Contact: sales@anamet.cz
  • Cold Spring Biotech CORP.minorChannel Partner/ Reseller/ DistributorRegional distribution partner for Taiwan, China. Contact: +886 2 2695 9990
  • Meiwafosis Co., Ltd.minorChannel Partner/ Reseller/ DistributorRegional distribution partner for Japan. Contact: international@meiwanet.co.jp
  • NewSpec Pty LtdminorChannel Partner/ Reseller/ DistributorRegional distribution partner for Australia. Contact: sales@newspec.com.au

Scale indicators4 records

Recent moves5 records

Expansion highlights6 records

NanoFCM competitors and assessment

Company assessment

Emerging players

  • Bio-Techne: Supplies exosome/EV reagents, antibodies, and isolation kits (ExoDx, ExoQuick). Overlaps with NanoFCM's reagent/consumables business and shares the same EV-research customer base, creating both partnership and competitive dynamics.
  • Nanoview Biosciences: Single-EV analysis platform (ExoView) using microarray-based immunocapture plus interferometric imaging. Direct competitor in the EV characterization market, frequently co-cited with NanoFCM in EV research publications.
  • RoosterBio: MSC and EV bioprocess supplier and NanoFCM's first US approved service provider for exosome/EV analytical services. Although a partner, RoosterBio also develops its own EV analytics offerings and competes for the same biopharma EV development budget.
  • Cytek Biosciences: Spectral flow cytometry innovator (Aurora, Northern Lights) bringing advanced flow-based cell analysis to immunology, cell therapy, and oncology. Overlaps with NanoFCM in serving cell-therapy and EV analytical workflows using flow-based single-particle measurement.
  • Spectradyne: Maker of nCS1 Microfluidic Resistive Pulse Sensing instruments for nanoparticle sizing and concentration. Competes with NanoFCM directly in LNP, EV, and viral vector characterization, particularly in biopharma QC.

Direct peers

  • Particle Metrix: Maker of ZetaView NTA systems that compete head-to-head with NanoFCM in EV/exosome quantification and characterization. Both target academic core facilities and biopharma process development with comparable single-particle workflows.
  • Malvern Panalytical (NanoSight): Maker of NanoSight Nanoparticle Tracking Analysis instruments, which is the most widely used competing technique for sub-micron particle sizing. Both NanoFCM and NanoSight target EV, LNP, and exosome characterization workflows in biopharma and academia.
  • Izon Science: Developer of qNano / TRPS tunable resistive pulse sensing instruments for single-particle nanoparticle sizing and concentration. Izon is the closest alternative technique to NanoFCM's single-particle analysis, serving overlapping EV, virus, and LNP characterization markets.

Broad incumbents

  • Beckman Coulter Life Sciences: Dominant flow cytometry incumbent (CytoFLEX, Navios, DxFLEX) with broad biopharma and clinical diagnostics reach. NanoFCM directly extends flow cytometry into the sub-500 nm range Beckman does not cover, making Beckman the most strategically relevant incumbent — and the most likely large competitor.
  • BD Biosciences: Global flow cytometry leader (BD FACSDiscover, BD Symphony) with the largest installed base in pharma and academia. BD has the resources to enter the nano-flow space and already supplies the broader cell-analysis workflow in which NanoFCM's EV/virus customers operate.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat5 records

Key risks6 records

Key highlights7 records

Customer concentration

NanoFCM social profiles

Digital presence

NanoFCM financial estimates

Financial estimate

Revenue estimate

Valuation estimate

NanoFCM leadership team

Management profile

Number of profiles

Profiles2 records

NanoFCM funding detail

Funding detail

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

NanoFCM M&A and investment

M&A and investment

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about NanoFCM

What does NanoFCM do?

NanoFCM designs, manufactures, and sells nano-flow cytometry instruments (Flow NanoAnalyzer and Single-Molecule NanoAnalyzer) for multiparameter analysis of individual biological nanoparticles in the 7-1000 nm range. The company combines light scattering for size/concentration measurement with fluorescence detection for biochemical characterization, and also supplies supporting reagents, consumables, and contract sample analysis services for biopharma and academic customers.

Is NanoFCM a public or private company?

NanoFCM is a private company. It is classified as unknown and is currently operating.

When was NanoFCM founded?

NanoFCM was founded in 2018. It employs 11 to 50 people.

Where is NanoFCM based?

NanoFCM is headquartered in Xiamen, China, in the Asia region.

How does NanoFCM make money?

Three revenue lines are on record. Flow NanoAnalyzer Instruments are the primary driver. The others are reagents and Consumables and sample Analysis Services.

Who are NanoFCM's main competitors?

Emerging players on record are Bio-Techne, Nanoview Biosciences, RoosterBio, Cytek Biosciences and Spectradyne. Direct peers are Particle Metrix, Malvern Panalytical (NanoSight) and Izon Science. Broad incumbents are Beckman Coulter Life Sciences and BD Biosciences.

Does NanoFCM have an API?

No public API is recorded for NanoFCM.

What industry is NanoFCM in?

NanoFCM's product category is Analytical Instrumentation. Its primary akta.pro industry code is HLAGAIAE, Microscopy, Imaging & Flow Cytometry Instruments, with a secondary code of HLAHAAAF, Flow Cytometry & Cellular Analysis Diagnostics. Its NAICS code is 334516 and its SIC code is 3826.

Unlock the full company data

50 free credits on sign-up, no credit card required.

Contact sales
Live signals